Skip to content
value.today

TyRx Pharma Inc

Formerly Advanced Materials Design, LLC, Advanced Materials Design, Inc.

Total raised
$36 M
3 rounds on record
Latest round
$2 M
May 2013
First round on record
Jul 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of TyRx Pharma Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2013$2 MNo. 3$2 to $10 million

TyRx Pharma Inc: Raise no. 3, May 2013

Investors in this round

1 investor had bought by the notice of May 15, 2013: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ray S. Imp · Executive Officer
  • Robert S. White · Executive Officer, Director
  • Arthur S. Pappas · Director
  • Edward G. Cahill · Director
  • Michael T. Heffernan · Director
  • Scott S. Requadt · Director
  • William G. Dempsey · Director
  • William S. Young · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert White, President and Chief Executive Officer. Source: SEC Form D, newest notice filed May 15, 2013. Read the notice at the SEC.

equitySEC
Nov 2010$23 MNo. 2$10 to $50 million

TyRx Pharma Inc: Raise no. 2, Nov 2010

Investors in this round

9 investors had bought by the notice of Dec 7, 2010: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $25 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Certain investors converted their convertible promissory notes to receive Series BB Preferred Stock pursuant to terms of the Series BB Preferred Stock Purchase Agreement.
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ray S. Imp · Executive Officer
  • Robert S. White · Executive Officer, Director
  • Arthur S. Pappas · Director
  • Edward G. Cahill · Director
  • Jeffrey S. Leiden · Director
  • Michael T. Heffernan · Director
  • Scott S. Requadt · Director
  • William G. Dempsey · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ray Imp, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 7, 2010. Read the notice at the SEC.

equitySEC
Jul 2009$11 MNo. 1$10 to $50 million

TyRx Pharma Inc: Raise no. 1, Jul 2009

Investors in this round

6 investors had bought by the notice of Aug 14, 2009: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $11 M offered
Smallest investment taken
$125,956
What was sold
debt, options or other rights to buy securities, other: Unsecured Convertible Promissory Notes and Warrants
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Arikha Moses · Executive Officer
  • Ray Imp · Executive Officer
  • William Edelman · Executive Officer, Director
  • Arthur Pappas · Director
  • Charles Cahn · Director
  • Jeff Leiden · Director
  • Mike Heffernan · Director
  • Scott Requadt · Director
  • William G. Dempsey · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The investors agreed to invest an aggregate of $6,500,000 at the Initial Closing and an additional $4,500,000 upon the attainment of certain milestones by the Issuer.”

Signed by Ray Imp, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 14, 2009. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • TyRx Pharma Inc chose not to state its revenue in its newest notice of a funding round (May 2013).

    SEC Form D · May 2013

  • The industry group it chose in its notices: Other.

    SEC Form D · May 2013

That is all the official record says: TyRx Pharma Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of TyRx Pharma Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 9 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by TyRx Pharma Inc
NameRoleNamed in
Ray S. ImpExecutive officerMay 2013
Robert S. WhiteExecutive officerMay 2013
Arikha MosesExecutive officerAug 2009
Ray ImpExecutive officerAug 2009
William EdelmanExecutive officerAug 2009
Arthur S. PappasDirectorMay 2013
Edward G. CahillDirectorMay 2013
Michael T. HeffernanDirectorMay 2013
Robert S. WhiteDirectorMay 2013
Scott S. RequadtDirectorMay 2013
William G. DempseyDirectorMay 2013
William S. YoungDirectorMay 2013
Jeffrey S. LeidenDirectorDec 2010
Arthur PappasDirectorAug 2009
Charles CahnDirectorAug 2009
Jeff LeidenDirectorAug 2009
Mike HeffernanDirectorAug 2009
Scott RequadtDirectorAug 2009
William EdelmanDirectorAug 2009